5 Stocks Under Wall Street’s Radar: Hewlett-Packard Company (NYSE:HPQ), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Banco Santander, S.A. (NYSE:SAN), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), PKG

Jefferies Group initiated coverage on shares of Hewlett-Packard Company (NYSE:HPQ) in a research report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a hold rating and a $38.00 price objective on the stock. Hewlett-Packard Company (NYSE:HPQ) belongs to Technology sector. Its net profit margin is 4.50% and weekly performance is 1.39%. On last trading day company shares ended up $36.38. Hewlett-Packard Company (NYSE:HPQ) distance from … Continue reading 5 Stocks Under Wall Street’s Radar: Hewlett-Packard Company (NYSE:HPQ), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Banco Santander, S.A. (NYSE:SAN), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), PKG

Chris Lewis11/1011/10

5 Stocks Under Wall Street’s Radar : AOL Inc. (NYSE:AOL), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), IntraLinks Holdings, Inc. (NYSE:IL), SBCF, ARLP

On Oct 07, AOL Inc. (NYSE:AOL) is reaching into the traditional media ranks as it looks to build an online video business that can compete head-to-head with television.The Web company has hired Dermot McCormack, who has held several digital media roles at–he recently ran Viacom Music & Logo’s Connect Content Group–as its new President of Video and Studios. AOL Inc. (NYSE:AOL) belongs to Technology sector. … Continue reading 5 Stocks Under Wall Street’s Radar : AOL Inc. (NYSE:AOL), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), IntraLinks Holdings, Inc. (NYSE:IL), SBCF, ARLP

Jayne Crisman10/1510/15

Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.11) by $0.14. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is -0.48%. On last trading day company shares ended up $4.18. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is … Continue reading Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

Ryan Holtz08/2608/26

Morning Alert: Bally Technologies (NYSE:BYI), CSX. (NYSE:CSX), Snap-on Incorporated (NYSE:SNA), Arena Pharmaceuticals (NASDAQ:ARNA), Greenhill & Co. (NYSE:GHL)

Scientific Games Corp. agreed to acquire slot-machine maker Bally Technologies, Inc. (NYSE:BYI) for about $3.3 billion, furthering a consolidation of the gaming-equipment industry. Bally shareholders will get $83.30 a share, representing a 38% premium to the stock’s closing price on Thursday. Bally Technologies, Inc. (NYSE:BYI) belongs to Services sector. Its net profit margin is 10.90% and weekly performance is 24.80%. On last trading day company … Continue reading Morning Alert: Bally Technologies (NYSE:BYI), CSX. (NYSE:CSX), Snap-on Incorporated (NYSE:SNA), Arena Pharmaceuticals (NASDAQ:ARNA), Greenhill & Co. (NYSE:GHL)

Mark Doerr08/0408/04

Trader’s Recap – SINA (NASDAQ:SINA) , Arena Pharmaceuticals (NASDAQ:ARNA) , FelCor Lodging Trust (NYSE:FCH) , Anixter (NYSE:AXE) , Genomic (NASDAQ:GHDX)

SINA Corp (NASDAQ:SINA)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Thursday. They currently have a $52.00 target price on the stock. Zacks‘s target price suggests a potential upside of 4.75% from the stock’s previous close. SINA Corp (NASDAQ:SINA) stock performance was -0.38% in last session and finished the day at $48.45. Traded volume was … Continue reading Trader’s Recap – SINA (NASDAQ:SINA) , Arena Pharmaceuticals (NASDAQ:ARNA) , FelCor Lodging Trust (NYSE:FCH) , Anixter (NYSE:AXE) , Genomic (NASDAQ:GHDX)

Jason Knox07/2507/25

Healthcare Active Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Bristol-Myers Squibb (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), TherapeuticsMD (NYSEMKT:TXMD), Boston Scientific (NYSE:BSX)

Arena Pharmaceuticals, Inc.’s (NASDAQ:ARNA ) shares dropped 9.4% following news that its CEO Jack Lief, has sold around 40% of his stake in the company. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -5.29% in last session and finished the day at $5.01. Traded volume was 7.44million shares in the last session and the average volume of the stock remained 4.98million shares. The beta of the … Continue reading Healthcare Active Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Bristol-Myers Squibb (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), TherapeuticsMD (NYSEMKT:TXMD), Boston Scientific (NYSE:BSX)

Kevin Long07/0907/09